Orient EuroPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,747	1,950	1,435	1,736	1,801	1,959
Short-Term Investments	129	135.9	174.26	159.52	70.8	80.8
Cash & Short-Term Investments	1,876	2,086	1,609	1,896	1,872	2,040
Cash Growth	31.79%	29.59%	-15.10%	1.27%	-8.25%	-12.19%
Accounts Receivable	794.24	817.68	847.2	783.01	730.48	580.03
Other Receivables	57.66	26.72	21.44	26.94	27.66	33.53
Receivables	851.9	844.41	868.64	809.94	758.15	613.55
Inventory	1,063	1,122	1,065	1,147	1,304	1,082
Prepaid Expenses	208.19	184	137.26	118.23	162.21	136.07
Other Current Assets	37.02	62.39	295.84	257.28	88.62	53.63
Total Current Assets	4,036	4,298	3,976	4,228	4,185	3,925
Property, Plant & Equipment	3,861	3,857	3,851	3,986	4,019	4,181
Long-Term Investments	2,263	2,607	2,296	1,064	533.57	416.83
Other Intangible Assets	52.05	51.45	43.76	42.69	43.01	78.16
Long-Term Deferred Tax Assets	595.45	605.58	623.1	677.16	588.05	631.87
Other Long-Term Assets	807.68	788.45	780.13	814.28	1,062	170.82
Total Assets	11,615	12,208	11,570	10,812	10,430	9,403
Accounts Payable	205.66	155.64	176.13	348.07	552.2	159.81
Accrued Expenses	-	361.17	296.94	274.85	353.04	390.66
Short-Term Debt	1,860	1,718	2,112	2,324	2,191	2,050
Current Portion of Long-Term Debt	-	283.18	379.89	272.31	350.18	246.82
Current Portion of Leases	31.71	26.09	38.79	41.95	44.06	25.78
Current Income Taxes Payable	136.68	129.2	20.21	138.39	16.02	55.52
Other Current Liabilities	688.9	241.02	283.6	312.65	286.42	303.12
Total Current Liabilities	2,923	2,915	3,308	3,712	3,793	3,232
Long-Term Debt	902.79	924.97	1,343	1,790	1,991	1,680
Long-Term Leases	309.54	307.64	354.37	412.89	447.92	218.46
Pension & Post-Retirement Benefits	44.83	45.46	47	58.69	59.82	66.99
Long-Term Deferred Tax Liabilities	657.05	640.39	670.13	651.99	671.26	728.29
Other Long-Term Liabilities	21.99	21.27	22.9	23.44	23.3	24.65
Total Liabilities	4,859	4,854	5,746	6,649	6,987	5,950
Common Stock	867.47	867.47	867.47	867.47	867.47	867.47
Additional Paid-In Capital	-	518.46	271.26	271.26	271.26	263.44
Retained Earnings	3,742	3,666	2,046	1,752	1,738	2,118
Comprehensive Income & Other	1,058	1,236	1,979	624.12	51.9	-307.04
Total Common Equity	5,668	6,287	5,164	3,514	2,929	2,942
Minority Interest	1,088	1,066	660.39	648	514.77	511.39
Shareholders' Equity	6,756	7,354	5,824	4,162	3,444	3,453
Total Liabilities & Equity	11,615	12,208	11,570	10,812	10,430	9,403
Total Debt	3,104	3,260	4,229	4,841	5,024	4,221
Net Cash (Debt)	-1,228	-1,175	-2,620	-2,946	-3,153	-2,181
Net Cash Per Share	-14.19	-13.54	-30.20	-33.88	-36.34	-25.08
Filing Date Shares Outstanding	86.14	86.75	86.75	86.75	86.75	86.75
Total Common Shares Outstanding	86.14	86.75	86.75	86.75	86.75	86.75
Working Capital	1,113	1,383	667.71	515.42	391.79	693.29
Book Value Per Share	65.80	72.48	59.53	40.51	33.76	33.91
Tangible Book Value	5,616	6,236	5,120	3,472	2,886	2,864
Tangible Book Value Per Share	65.20	71.89	59.03	40.02	33.27	33.01
Land	-	1,154	1,157	1,169	1,169	1,462
Buildings	-	2,306	2,300	2,347	2,243	2,190
Machinery	-	1,124	1,083	1,069	992.9	965.5
Construction In Progress	-	159.43	27.78	3.55	36.12	48.41